Skip to content

Medical emergency? What to do

Programs Help Blacks Get Needed Colorectal Cancer Screening

3-RXPublished October 29, 20103 min read

Key points

  • African-Americans are less likely than whites to be screened for colorectal cancer, and the disparity almost certainly contributes to higher mortality.
  • The studies’ lack of long term follow-up represents “a gap in research,” however.
  • Screening promotion programs were most frequently offered in primary care health centers and community-based settings like churches and senior centers.
  • While a number of studies included interventions to overcome such screening barriers as fear and misconceptions about cancer, it was unclear how effective they were, she said.

African-Americans are less likely than whites to be screened for colorectal cancer, and the disparity almost certainly contributes to higher mortality. A new review of studies identifies effective strategies for improving the situation, but suggests that work remains to be done.

“We have seen some success in interventions, and shown that it’s important to tailor approaches to African American individuals and to use multiple approaches, strategies, and communication media,” said review author Barbara Powe, Ph.D.

The studies’ lack of long term follow-up represents “a gap in research,” however. “We need to learn to design interventions to create patterns of screening that could enhance screening for other cancers as well,” said Powe, a registered nurse and director of Cancer Communication Science for the American Cancer Society.

The review, which appears in the November/December issue of the American Journal of Health Promotion, examined findings from 12 studies in which 116 to 2283 people participated, most of whom were African-American.

Screening promotion programs were most frequently offered in primary care health centers and community-based settings like churches and senior centers. Several programs added personal communication efforts like informational letters, mailed fecal blood testing kits and phone calls.

Most programs addressed problems in access, such as cost and transportation, and some aimed to enlist active participation from doctors and nurses, but these efforts were often not described in detail, Powe said. “If a patient sees his or her provider for non-emergency health problems, are we missing an opportunity to promote cancer screening?”

While a number of studies included interventions to overcome such screening barriers as fear and misconceptions about cancer, it was unclear how effective they were, she said.

To Samir Soneji, Ph.D., the most striking finding of the review was that “intervention studies could be stronger and address barriers more directly. It seems that some of the larger studies didn’t show too much improvement between the intervention and control group.”

The review suggests that “we’re looking at this challenging dilemma piecemeal,” and presents a powerful argument for “a more unified approach,” said Soneji, an assistant professor at the Norris Cotton Cancer Center and the Dartmouth Institute for Health Policy and Clinical Practice,.

Soneji, whose own recent research showed higher mortality among African-Americans regardless of the stage at which colorectal cancer was diagnosed, called these findings complementary.

“If you combine Dr. Powe’s study and our study, you get a very disturbing picture of colorectal cancer among African Americans,” he said. “There are ever-widening disparities — in screening, staging, treatment, survival — between those with most and least resources.”

American Journal of Health Promotion: Call (248) 682-0707 or visit www.healthpromotionjournal.com.

Powe BD, Faulkenberry R, Harmond L. A review of intervention studies that seek to increase colorectal cancer screening among African-Americans. Am J Health Promo 25(2), 2010.

###

Source: Health Behavior News Service

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Tumors of the Gastrointestinal tract

Esophageal tumor

The most common malignant esophageal tumor is squamous cell carcinoma, followed by adenocarcinoma. Symptoms are progressive dysphagia and weight loss. Diagnosis is by endoscopy, followed by CT and endoscopic…

10 min read

Colon cancer

Penile and Urethral Carcinoma

Penile and urethral carcinomas are rare. Most physicians will never be involved in the management of such a case. Because of their rarity, delay in diagnosis secondary to both patient and physician factors are a…

12 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.